Get started
Author

Shinichi Nakatoh

Observed name: S. Nakatoh
ORCID: 0000-0001-7928-0014
Observed ORCID: 0000-0001-7928-0014
OpenAlex ID: A5032501751
Estimates of hip fracture incidence in Japan using the National Health Insurance Claim Database in 2012–2015
2019 · J. Tamaki, K. Fujimori, et al. · Osteoporosis International · 97
Intracortical facilitation and inhibition after paired magnetic stimulation in humans under anesthesia
1995 · Hiroshi Nakamura, Hideki Kitagawa, et al. · Neuroscience Letters · 39
Magnetic-Evoked Compound Muscle Action Potential Neuromonitoring in Spine Surgery
1995 · Hideki Kitagawa, Hiroshi Nakamura, et al. · Spine · 30
Insufficient increase in bone mineral density testing rates and pharmacotherapy after hip and vertebral fracture: analysis of the National Database of Health Insurance Claims and Specific Health Checkups of Japan
2021 · Shinichi Nakatoh, Kenji Fujimori, et al. · Archives of Osteoporosis · 28
Insufficient persistence to pharmacotherapy in Japanese patients with osteoporosis: an analysis of the National Database of Health Insurance Claims and Specific Health Checkups in Japan
2021 · Shinichi Nakatoh, Kenji Fujimori, et al. · Archives of Osteoporosis · 24
Early‐onset dementia and risk of hip fracture and major osteoporotic fractures
2024 · Shoya Matsumoto, Tatsuya Hosoi, et al. · Alzheimer s & Dementia · 17
PDF
Average daily glucocorticoid dose, number of prescription days, and cumulative dose in the initial 90 days of glucocorticoid therapy are associated with subsequent hip and clinical vertebral fracture risk: a retrospective cohort study using a nationwide health insurance claims database in Japan
2024 · Masayuki Iki, Kenji Fujimori, et al. · Osteoporosis International · 16
Bone turnover rate and bone formation/resorption balance during the early stage after switching from a bone resorption inhibitor to denosumab are predictive factors of bone mineral density change
2017 · Shinichi Nakatoh · Osteoporosis and Sarcopenia · 15
PDF
Insufficient persistence of and adherence to osteoporosis pharmacotherapy in Japan
2021 · Shinichi Nakatoh, Kenji Fujimori, et al. · Journal of Bone and Mineral Metabolism · 14
Delayed Initiation of Anti-Osteoporosis Medications Increases Subsequent Hip and Vertebral Fractures in Patients on Long-Term Glucocorticoid Therapy: A Nationwide Health Insurance Claims Database Study in Japan
2022 · Masayuki Iki, Kenji Fujimori, et al. · Bone · 13
The importance of assessing the rate of bone turnover and the balance between bone formation and bone resorption during daily teriparatide administration for osteoporosis: a pilot study
2015 · Shinichi Nakatoh · Journal of Bone and Mineral Metabolism · 13
Relationship between antidementia medication and fracture prevention in patients with Alzheimer’s dementia using a nationwide health insurance claims database
2023 · Tatsuya Hosoi, Mitsutaka Yakabe, et al. · Scientific Reports · 12
PDF
Effect of osteoporosis medication on changes in bone mineral density and bone turnover markers after 24-month administration of daily teriparatide: comparison among minodronate, raloxifene, and eldecalcitol
2017 · Shinichi Nakatoh · Journal of Bone and Mineral Metabolism · 12
Effects of coil orientation and magnetic field shield on transcranial magnetic stimulation in cats
1998 · Shinichi Nakatoh, Hideki Kitagawa, et al. · Muscle & Nerve · 12
Guideline adherence by physicians for management of glucocorticoid-induced osteoporosis in Japan: a nationwide health insurance claims database study
2022 · M. Iki, K. Fujimori, et al. · Osteoporosis International · 10
Insufficient increase in bone mineral density testing rates and pharmacotherapy after hip fracture in Japan
2020 · Shinichi Nakatoh, Kenji Fujimori, et al. · Journal of Bone and Mineral Metabolism · 10
Prescription of vitamin D was associated with a lower incidence of hip fractures
2023 · Mitsutaka Yakabe, Tatsuya Hosoi, et al. · Scientific Reports · 9
PDF
Application of the fracture risk assessment tool (FRAX®) and determination of suitable cut-off values during primary screening in specific health check-ups in Japan
2013 · Shinichi Nakatoh, Yuki Takemaru · Journal of Bone and Mineral Metabolism · 9
Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan
2024 · Masayuki Iki, Kenji Fujimori, et al. · Osteoporosis International · 8
Relationships between chronic pain with locomotive syndrome and somatic symptom disorder in general community-dwelling population: A cross-sectional evaluation of individuals aged 50 years or older undergoing primary specific health screening
2019 · Shinichi Nakatoh · Modern Rheumatology · 8
Change of Muscle Motor-Evoked Potentials After Motor Cortex Stimulation Caused by Acute Spinal Cord Injury in Cats
2001 · Shinichi Nakatoh, Hideki Kitagawa, et al. · Journal of Spinal Disorders · 7
Real-World Effectiveness of Anti-Osteoporosis Medications for the Prevention of Incident Hip and Vertebral Fractures in Patients on Long-Term Glucocorticoid Therapy: A Nationwide Health Insurance Claims Database Study in Japan
2022 · Masayuki Iki, Kenji Fujimori, et al. · Bone · 6
Hip and vertebral fracture risk after initiating antidiabetic drugs in Japanese elderly: a nationwide study
2022 · Junko Tamaki, Sumito Ogawa, et al. · Journal of Bone and Mineral Metabolism · 5
Screening program including the Loco-check and fracture risk assessment tool (FRAX®) questionnaires for assessing locomotive syndrome in a municipality in Japan: A pilot study
2018 · Shinichi Nakatoh · Journal of Orthopaedic Science · 5
Association of pharmacotherapy with the second hip fracture incidence in women: A retrospective analysis of the National Database of Health Insurance Claims and Specific Health Checkups of Japan
2022 · Shinichi Nakatoh, Kenji Fujimori, et al. · Geriatrics and gerontology international/Geriatrics & gerontology international · 4
Works count: 42
Citation count: 438
H-index: 12
I10-index: 16
Year
Topic
Type